Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: From impaired tubules to impaired carotid and coronary arteries

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 4, 2008, Pages 986-991

  Turkmen, Kultigin ^a   Oflaz, Huseyin ^a   Uslu, Bora ^a   Cimen, Arif O ^a   Elitok, Ali ^a   Kasikcioglu, Erdem ^a   Alisir, Sabahat ^b   Tufan, Fatih ^a   Namli, Sule ^a   Uysal, Mukremin ^a   Ecder, Tevfik ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CAROTID ARTERY; CASE CONTROL STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; ECHOGRAPHY; FEMALE; HUMAN; INTIMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; STRESS ECHOCARDIOGRAPHY; TUNICA MEDIA;

ADULT; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CAROTID ARTERIES; CASE-CONTROL STUDIES; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; KIDNEY TUBULES; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TUNICA INTIMA; TUNICA MEDIA;

EID: 49149106386     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02330607     Document Type: Article

References (40)

1. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332-342, 1993
2. Iglesias CG, Torres VE, Offord K, Holley KE, Beard CM, Kurland LT: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 2: 630-639, 1983
3. Fick GM, Johnson AM, Hammond WS, Gabow PA: Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 2048-2056, 1995
4. Ecder T, Schrier RW: Hypertension in autosomal dominant polycystic kidney disease: Early occurrence and unique aspects. J Am Soc Nephrol 12: 194-200, 2001
5. Schrier RW, McFann KK, Johnson AM: Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 63: 678-685, 2003
6. Chapman AB, Johnson A, Gabow PA, Schrier RW: The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323: 1091-1096, 1990
7. Harrap SB, Davies DL, Macnicol AM, Dominiczak AF, Fraser R, Wright AF, Watson ML, Briggs JD: Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int 40: 501-508, 1991
8. Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P: Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int 46: 118-1123, 1994
9. Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8: 1292-1297, 1997
10. Martinez-Vea A, Valero FA, Bardaji A, Gutierrez C, Broch M, Garcia C, Richart C, Oliver JA: Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: Influence of blood pressure and humoral and neurohumoral factors. Am J Nephrol 20: 193-200, 2000
11. Saggar-Malik AK, Missouris CG, Gill JS, Singer DR, Markandu ND, MacGregor GA: Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ 309: 1617-1618, 1994
12. Bardaji A, Martinez-Vea A, Gutierrez C, Ridao C, Richart C, Oliver JA: Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 32: 970-975, 1998
13. Zeier M, Geberth S, Schmidf KG, Mandelbaum A, Ritz E: Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3: 1451-1457, 1993
14. Valero FA, Martinez-Vea A, Bardaji A, Gutierrez C, Garcia C, Richart C, Oliver JA: Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 10: 1020-1026, 1999
15. Oflaz H, Alisir S, Buyukaydin B, Kocaman O, Turgut F, Namli S, Pamukcu B, Oncul A, Ecder T: Biventricular diastolic dysfunction in patients with autosomal dominant polycystic kidney disease. Kidney Int 68: 2244-2249, 2005
16. Martinez-Vea A, Bardaji A, Gutierrez C, Garcia C, Peralta C, Marcas L, Oliver JA: Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: A prehypertensive state. Am J Kidney Dis 44: 216-223, 2004
17. Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T: Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 43: 854-860, 2004
18. Hozumi T, Yoshida K, Ogata Y, Akasaka T, Asami Y, Takagi T, Morioka S: Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 97: 1557-1562, 1998
19. Rigo F: Coronary flow reserve in stress-echo lab: From pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound 3: 8, 2005
20. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824-827, 1994
21. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
22. Sahn DJ, Demaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978
23. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, Sahn DJ, Schiller NB, Tajik A, Teichholz LE, Weyman AE: Report of the American Society of Echocardiography Committee on nomenclature and standards in two dimensional echocardiography. Circulation 62: 212-217, 1980
24. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 55: 613- 618, 1977
25. Martinez-Vea A, Gutierrez C, Bardaji A, Pastor R, Garcia C, Peralta C, Richart C, Oliver JA: Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease. Scand J Urol Nephrol 32: 356-359, 1998
26. Brunner HR: Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. Am J Cardiol 87: 3C-9C, 2001
27. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ: Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 66: 22D-30D, 1990
28. Wolf G: Angiotensin II: A pivotal factor in the progression of renal diseases. Nephrol Dial Transplant 14[Suppl 1]: S42-S44, 1999
29. Luscher TF: Endothelial dysfunction: The role and impact of renin-angiotensin system. Heart 84[Suppl 11: Si20-Si22, 2000
30. Brasier AR, Recinos A III, Eledrisi MS: Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22: 1257-1266, 2002
31. Wang D, Iversen J, Wilcox CS, Strangaard S: Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal dominant polycystic kidney disease. Kidney Int 64: 1381-1388, 2003
32. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: 1899-1906, 2000
33. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954, 2000
34. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, Gallopin M, Salvadori P, Carpegiani C, Poddighe R, L'Abbate A, Parodi O: Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105: 186-193, 2002
35. Skalidis EI, Parthenakis FI, Patrianakos P, Hamilos MI, Vardas PE: Regional coronary flow and contractility reserve in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 44: 2027-2032, 2004
36. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG: Coronary microcirculatory dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349: 1027-1035, 2003
37. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, Omata M: Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 30: 1472-1477, 1997
38. Galiuto L, Sestito A, Barchetta S, Squeglia GA, Infusino F, La Rosa C, Lanza G, Crea F: Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol 99: 1378-1383, 2007
39. Galderisi M, Cicala S, Caso P, De Simone L, D'Errico A, Petrocelli A, de Divitiis O: Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90: 860-864, 2002
40. Kamezaki F, Tasaki H, Yamashita K, Shibata K, Hirakawa N, Tsutsui M, Kouzuma R, Nagatomo T, Adachi T, Otsuji Y: Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: Comparison with calcium channel blocker. Hypertens Res 30: 699-706, 2007